March 16, 2011 15:48 ET

Global Spending on Mammography Equipment Reached $1.6 Billion in 2010; To Reach $2.5 Billion in 2016

NEW YORK, NY--(Marketwire - March 16, 2011) - cites in its newly published "Mammography World Markets" report that global spending on mammography equipment was $1.6 billion in 2010 and is predicted to reach $2.5 billion in 2016. For more information, visit:

Breast cancer is the most common type of cancer in women. Mammography is the most valuable method for detecting potentially cancerous anomalies in the breast. Mammograms are images of breast tissue produced from low radiation X-rays. The three types of mammography systems are: 1) analog systems, 2) computed tomography (CR) systems and 3) full-field digital mammography (FFDM). Digital tomosynthesis is a new technology with improved diagnostic capabilities over standard digital mammography. Scintimammography (nuclear medicine breast imaging) is an additional breast exam available. The total number of mammograms in the U.S. was about 37.5 million in 2010, and with 3% growth, it is likely to reach 44.74 million in 2016. estimates that the mammography equipment market in the U.S. was worth about $470.21 million in 2010, and it is set to reach $585 million in 2016.

The "Mammography World Markets" report covers:

  • Existing and Emerging Mammography Technologies
  • Known Risk Factors for Breast Cancer
  • Breast Cancer Treatments and Drugs
  • Types of Mastectomy Procedures
  • Breast Reconstruction Surgery
  • Funding for Breast Cancer Research

The "Mammography World Markets" report examines companies manufacturing mammography equipment and providing breast cancer therapies. Companies covered include: Abviva, Agendia, Agfa Healthcare, Amgen, Analogic, Ardent Sound, AstraZeneca, Aurora Imaging, Biosound Esaote, Bristol-Myers Squibb, Canon, Clarient, Dako, Dilon, Eli Lilly, Fonar, Fujifilm, Fukuda Denshi, GE Healthcare, Genentech, Hitachi Medical, Hologic, Konica Minolta, Lantheus, Medis, Medison America, Medtronic, MeVis, Naviscan, Novartis, Pfizer, Philips Healthcare, Roche, Sanofi-Aventis, Sectra, SenoRx, Shimadzu, Siemens Healthcare, Toshiba, U-Systems, Varian and VuCOMP.

Detailed charts with sales forecasts and marketshare data are included. For more information, visit:

About is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.

Contact Information